Overview

A Study of ONO-1110 in Patients With Postherpetic Neuralgia

Status:
RECRUITING
Trial end date:
2026-08-31
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of ONO-1110 in Japanese patients with postherpetic neuralgia
Phase:
PHASE2
Details
Lead Sponsor:
Ono Pharmaceutical Co. Ltd